Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Effect of Stellate Ganglion Block on ME/CFS
Phase 1
Completed
- Conditions
- Encephalomyelitis, MyalgicChronic Fatigue SyndromeChronic Fatigue DisorderChronic Fatigue and Immune Dysfunction SyndromeMyalgic EncephalomyelitisPostviral Fatigue SyndromeSystemic Exertion Intolerance DiseaseInfectious Mononucleosis-Like Syndrome, ChronicChronic Fatigue-Fibromyalgia Syndrome
- Interventions
- First Posted Date
- 2022-12-27
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- Neuroversion, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT05664711
- Locations
- 🇺🇸
Neuroversion, Anchorage, Alaska, United States
News
No news found